CBOA
AGN

Commonwealth Bank of Australia’s Allergan Inc AGN Stock Holding History

Commonwealth Bank of Australia’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,544
Closed -$2.03M – 788
2014
Q4 		$2.03M Sell
9,544
-7,933
-45% -$1.58M 0.03% 284
2014
Q3 		$3.11M Sell
17,477
-300
-2% -$49.8K 0.04% 241
2014
Q2 		$3.01M Sell
17,777
-19,170
-52% -$2.98M 0.04% 250
2014
Q1 		$4.58M Buy
36,947
+2,800
+8% +$341K 0.03% 460
2013
Q4 		$3.79M Buy
34,147
+7,598
+29% +$726K 0.03% 489
2013
Q3 		$2.4M Buy
26,549
+1,200
+5% +$108K 0.02% 561
2013
Q2 		$2.13M Buy
+25,349
New +$2.63M 0.02% 563

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Commonwealth Bank of Australia's AGN Position: Q1 2015 in Review

Commonwealth Bank of Australia sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 9,544 shares — an estimated $2.03M sold.

Commonwealth Bank of Australia first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.58M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Commonwealth Bank of Australia reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 9,544 Allergan Inc shares in Q1 2015, an estimated $2.03M.
  • Commonwealth Bank of Australia first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Commonwealth Bank of Australia's Allergan Inc position peaked at $4.58M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Commonwealth Bank of Australia's 13F filing for Q1 2015, filed 15 May 2015.